Literature DB >> 12379173

The effects of errors in lipid measurement and assessment.

Gerald R Cooper1, Gary L Myers, Mary M Kimberly, And Parvin P Waymack.   

Abstract

Accurate cholesterol and lipoprotein measurements have provided dependable and powerful basic risk factors for cardiovascular disease. A battery of total cholesterol (TC), high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol, and triglycerides (TG) is recommended in the initial evaluation for classification of patients (based on lipids) into highly desirable, desirable, borderline, high, and very high lipid risk factor for cardiovascular disease. Treatment is based largely on the LDL cholesterol measurement result of the patient. The risk factor score of a patient greatly increases when other risk factors for cardiovascular disease exist, along with increased lipid risk factors. Attainment of the needed acceptable accurate lipid and lipoprotein measurements depends upon prevention or control of multiple sources of errors or variation that can exist in preanalytic, analytic, and postanalytic stages of determination of the reported result. Highly important is to control nonfasting, posture, diet, and alcohol intake in the preanalytic part, elimination of matrix effects and use of accurate calibrators in the analytic part, and check for transcription errors in preparation of reports in the postanalytic part of the measurement of lipids.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379173     DOI: 10.1007/s11886-002-0114-5

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  29 in total

1.  Laboratory-based calculation of coronary heart disease risk.

Authors:  T Geberhiwot; A F Jones; W A Bartlett; D Husband; S C Martin
Journal:  Clin Chem       Date:  2001-03       Impact factor: 8.327

2.  Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation.

Authors:  R B D'Agostino; S Grundy; L M Sullivan; P Wilson
Journal:  JAMA       Date:  2001-07-11       Impact factor: 56.272

3.  Biochemical risk factors for cardiovascular disease in an aged male population: emerging vascular pathogens.

Authors:  G Lippi; E Arosio; M Prior; G Guidi
Journal:  Angiology       Date:  2001-10       Impact factor: 3.619

4.  Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

Authors:  S M Haffner; M P Stern; H P Hazuda; B D Mitchell; J K Patterson
Journal:  JAMA       Date:  1990-06-06       Impact factor: 56.272

5.  Reevaluation of serum-plasma differences in total cholesterol concentration.

Authors:  T Cloey; P S Bachorik; D Becker; C Finney; D Lowry; W Sigmund
Journal:  JAMA       Date:  1990 May 23-30       Impact factor: 56.272

6.  Lipids, lipoproteins, and apoproteins in serum during infection.

Authors:  C Alvarez; A Ramos
Journal:  Clin Chem       Date:  1986-01       Impact factor: 8.327

7.  Assessment of current National Cholesterol Education Program guidelines for total cholesterol triglyceride, HDL-cholesterol, and LDL-cholesterol measurements.

Authors:  S P Caudill; G R Cooper; S J Smith; G L Myers
Journal:  Clin Chem       Date:  1998-08       Impact factor: 8.327

8.  Establishment of reference methods for lipids, lipoproteins and apolipoproteins.

Authors:  G R Cooper; G L Myers; L O Henderson
Journal:  Eur J Clin Chem Clin Biochem       Date:  1991-04

9.  Increased plasma triglycerides, cholesterol and apolipoprotein E during prolonged fasting in normal subjects.

Authors:  A Markel; J G Brook; M Aviram
Journal:  Postgrad Med J       Date:  1985-05       Impact factor: 2.401

10.  Increases in serum lipid and lipoprotein levels with movement from the supine to standing position in adult men and women.

Authors:  R D Hagan; S J Upton; E V Avakian; S Grundy
Journal:  Prev Med       Date:  1986-01       Impact factor: 4.018

View more
  2 in total

1.  Developing a synthetic control group using electronic health records: Application to a single-arm lifestyle intervention study.

Authors:  Yi-An Ko; Zhenchao Chen; Chang Liu; Yingtian Hu; Arshed A Quyyumi; Lance A Waller; Melinda Higgins; Thomas R Ziegler; Kenneth L Brigham; Greg S Martin
Journal:  Prev Med Rep       Date:  2021-10-04

2.  Assessing the prevalence of the Metabolic Syndrome according to NCEP ATP III in Germany: feasibility and quality aspects of a two step approach in 1550 randomly selected primary health care practices.

Authors:  Susanne Moebus; Jens Ulrich Hanisch; Markus Neuhäuser; Pamela Aidelsburger; Jürgen Wasem; Karl-Heinz Jöckel
Journal:  Ger Med Sci       Date:  2006-10-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.